cetylpyridinium chloride anhydrous has been researched along with tamoxifen in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Faulder, C | 1 |
| Raloff, J | 1 |
| Carlson, LE; Joy, AA; Palmer, JL; Trotter, T | 1 |
3 other study(ies) available for cetylpyridinium chloride anhydrous and tamoxifen
| Article | Year |
|---|---|
Better safe than sorry.
Topics: Consent Forms; Disclosure; Ethics Committees; Ethics Committees, Research; Female; Health; Human Experimentation; Humans; Information Dissemination; Information Services; Informed Consent; Multicenter Studies as Topic; Neoplasms; Patient Selection; Pharmaceutical Preparations; Placebos; Preventive Medicine; Random Allocation; Research; Research Design; Research Subjects; Risk; Risk Assessment; Tamoxifen; Therapeutic Human Experimentation; United Kingdom; Volunteers; Women | 1992 |
Tamoxifen turmoil: new issues emerge as healthy women volunteer to take a potent drug.
Topics: Academies and Institutes; Breast Neoplasms; Canada; Consent Forms; Disclosure; Drug-Related Side Effects and Adverse Reactions; Endometrial Neoplasms; Female; Health; Hormones; Human Experimentation; Humans; Informed Consent; Mortality; Multicenter Studies as Topic; Pharmaceutical Preparations; Physicians; Placebos; Preventive Medicine; Research Personnel; Research Subjects; Risk; Risk Assessment; Tamoxifen; United States; Volunteers; Women | 1994 |
Cognitive effects of Tamoxifen in pre-menopausal women with breast cancer compared to healthy controls.
Topics: Adult; Antineoplastic Agents, Hormonal; Breast Neoplasms; Case-Control Studies; Cognition; Cross-Sectional Studies; Female; Health; Humans; Middle Aged; Neuropsychological Tests; Premenopause; Retrospective Studies; Tamoxifen | 2008 |